259 related articles for article (PubMed ID: 26118953)
1. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha protects cardiomyocytes from hypertrophy by suppressing calcineurin-nuclear factor of activated T cells c4 signaling pathway.
Liu XP; Gao H; Huang XY; Chen YF; Feng XJ; He YH; Li ZM; Liu PQ
Transl Res; 2015 Nov; 166(5):459-473.e3. PubMed ID: 26118953
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Disruption Is Involved in the Effect of Nuclear Factor of Activated T cells, Cytoplasmic 4 on Aggravating Cardiomyocyte Hypertrophy.
Liu X; Gao S; Gao H; Jiang X; Wei Q
J Cardiovasc Pharmacol; 2021 May; 77(5):557-569. PubMed ID: 33951694
[TBL] [Abstract][Full Text] [Related]
3. The protective role of peroxisome proliferator-activated receptor γ coactivator-1α in hyperthyroid cardiac hypertrophy.
Xu W; Hou D; Jiang X; Lu Z; Guo T; Liu Y; Wang D; Zen K; Yu B; Zhang CY
J Cell Physiol; 2012 Sep; 227(9):3243-53. PubMed ID: 22105890
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
5. [Effects of hydrogen sulfide (H
Wu Y; Guo YY; Zhang YY; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
[TBL] [Abstract][Full Text] [Related]
6. NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy.
Li M; He HP; Gong HQ; Zhang J; Ma WJ; Zhou H; Cao DS; Wang N; Zhang TC
Life Sci; 2016 Jun; 155():11-20. PubMed ID: 27155398
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.
Zou J; Le K; Xu S; Chen J; Liu Z; Chao X; Geng B; Luo J; Zeng S; Ye J; Liu P
Mol Cell Endocrinol; 2013 May; 370(1-2):103-12. PubMed ID: 23518069
[TBL] [Abstract][Full Text] [Related]
8. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
9. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
10. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
Asadi F; Razmi A; Dehpour AR; Shafiei M
J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895
[TBL] [Abstract][Full Text] [Related]
11. PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Le K; Li R; Xu S; Wu X; Huang H; Bao Y; Cai Y; Lan T; Moss J; Li C; Zou J; Shen X; Liu P
Arch Biochem Biophys; 2012 Feb; 518(1):71-8. PubMed ID: 22198280
[TBL] [Abstract][Full Text] [Related]
12. Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro.
Zhai X; Qiao H; Guan W; Li Z; Cheng Y; Jia X; Zhou Y
Eur J Pharmacol; 2015 Jan; 746():56-62. PubMed ID: 25445048
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
[TBL] [Abstract][Full Text] [Related]
14. Roles of transcriptional corepressor RIP140 and coactivator PGC-1α in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes.
Chen Y; Wang Y; Chen J; Chen X; Cao W; Chen S; Xu S; Huang H; Liu P
Mol Cell Endocrinol; 2012 Oct; 362(1-2):11-8. PubMed ID: 22503866
[TBL] [Abstract][Full Text] [Related]
15. Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy.
Li R; Zheng W; Pi R; Gao J; Zhang H; Wang P; Le K; Liu P
FEBS Lett; 2007 Jul; 581(17):3311-6. PubMed ID: 17597616
[TBL] [Abstract][Full Text] [Related]
16. Novel PGC-1
Zhang B; Tan Y; Zhang Z; Feng P; Ding W; Wang Q; Liang H; Duan W; Wang X; Yu S; Liu J; Yi D; Sun Y; Yi W
Oxid Med Cell Longev; 2020; 2020():9187065. PubMed ID: 33425220
[TBL] [Abstract][Full Text] [Related]
17. Cardiac hypertrophy drives PGC-1α suppression associated with enhanced O-glycosylation.
Brainard RE; Facundo HT
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166080. PubMed ID: 33486096
[TBL] [Abstract][Full Text] [Related]
18. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
19. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
Sugiyama A; Okada M; Yamawaki H
Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
[TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y
Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
